GLUC
Glucose Health, Inc.Company Information
- Company Name
- Glucose Health, Inc.
- CIK
- CIK0001420108
- Category
- Smaller reporting company
- Ticker: Exchange
- GLUC: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- GLUC
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2017-11-14
- Price on filing date
- —
- 1-month reaction
- -0.87%
- 3-month reaction
- -38.26%
Balance Sheet
Values in millions ($)| Line item | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Inventory Net | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Due From Affiliates | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Prepaid Expense Current | 0 | - | - | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
Other Assets | ||||||||||||||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Interest Payable Current | - | - | - | - | 0 | 0 | - | - | - | - | - | - | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | ||||||
| Notes Payable Related Parties Classified Current | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Notes Payable Current | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Common Stock Shares Subscriptions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -0 | -0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Cash | - | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Accumulated Amortization Of Noncurrent Deferred Finance Costs | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | - | - | 0 | ||||||
| Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | ||||||
| Shares Outstanding | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGlucose Health, Inc. (GLUC) — SEC Financial Statements & Analysis
Glucose Health, Inc. (GLUC) is a medicinal chemicals & botanical products company, incorporated in DE. Glucose Health, Inc. trades on OTC as: GLUC. Glucose Health, Inc. (GLUC)'s most recent SEC filing is a Form 10-Q for the period ended 2017-09-30, filed with the SEC on 2017-11-14. Based on that filing, Glucose Health, Inc. carries a market cap of $954.06K, a P/E ratio of -10.15x, a P/B ratio of -2.24x, a P/S ratio of 10.83x, an enterprise value of $1.06M, and an EV/EBITDA multiple of -32.70x. On profitability, it posts a gross margin of 65.39%, an operating margin of -36.82%, a net margin of -106.63%, a Return on Equity (ROE) of 23.50%, and a Return on Assets (ROA) of -267.29%. Per share, it reports EPS of $-0.02, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -70.59% year-over-year, net income growth of -71.02% year-over-year, and EPS growth of -79.90% year-over-year. On the balance sheet, it maintains a current ratio of 0.06x, a quick ratio of 0.06x, working capital of $-426.43K, a debt-to-equity ratio of -1.06x, a debt ratio of 17.17, an interest coverage ratio of -0.27x, free cash flow of $-17.25K (TTM), and net debt of $105.52K. Figures sourced from SEC EDGAR.
- Market Cap
- $954.06K
- P/E TTM
- -10.15x
- EPS TTM
- $-0.02
- P/B TTM
- -2.24x
- ROE TTM
- 23.50%
- ROA TTM
- -267.29%
- Debt To Equity
- -1.06x
- Free Cash Flow TTM
- $-17.25K
- Net Revenue TTM Growth 1Y
- -70.59%
Data as of 2017-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Glucose Health, Inc. in?
Glucose Health, Inc. (GLUC) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does GLUC trade on?
Glucose Health, Inc. (GLUC) trades on the OTC.
Where is Glucose Health, Inc. incorporated?
Glucose Health, Inc. is incorporated in DE.
When was Glucose Health, Inc. (GLUC)'s most recent SEC filing?
Glucose Health, Inc. (GLUC)'s most recent SEC filing is a Form 10-Q for the period ended 2017-09-30, filed with the SEC on 2017-11-14.
What is GLUC's market cap?
Glucose Health, Inc. (GLUC) has a market capitalization of $954.06K as of 2017-09-30.
What is GLUC's EPS (earnings per share)?
Glucose Health, Inc. (GLUC)'s trailing twelve month EPS is $-0.02 as of 2017-09-30.
What is GLUC's ROE (return on equity)?
Glucose Health, Inc. (GLUC)'s trailing twelve month Return on Equity (ROE) is 23.50% as of 2017-09-30.
What is GLUC's ROA (return on assets)?
Glucose Health, Inc. (GLUC)'s trailing twelve month Return on Assets (ROA) is -267.29% as of 2017-09-30.
What is GLUC's EV/EBITDA?
Glucose Health, Inc. (GLUC)'s trailing twelve month EV/EBITDA is -32.70x as of 2017-09-30.